Investor Type | Firm |
Industries | BioTech • Medical Devices (& Hospital Services) • Oncology |
Investing | United Kingdom |
Investment Range | $2,940,000 - $2,940,000 |
Excalibur Group Holdings is a London, United Kingdom-based venture capital firm. The firm is a link between research, development, production, commercialization, supply and distribution of drugs, devices, diagnostics and facilities with individual and institutional investors, equity and debt markets, start-up and expansion capital, strategic advice and ultimately trade sale or flotation. It primarily invests in the biotechnology, healthcare and life science sectors.